Receptos' Series B Round

Receptos raised a round of funding on February 17, 2012.

Receptos (NASDAQ: RCPT) is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics in immune disease. The company's lead asset, RPC1063, is being dev…

Articles about Receptos' Series B Round: